Journal article

Everolimus for renal angiomyolipoma in tuberous sclerosis.

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Share
Cite

Cite this record

APA Style

Sooriakumaran, P., & Anderson, C. (2013). Everolimus for renal angiomyolipoma in tuberous sclerosis. Lancet, 381(9869), 783–785.

MLA Style

Sooriakumaran, P, and C Anderson. “Everolimus for Renal Angiomyolipoma in Tuberous Sclerosis.” Lancet, vol. 381, no. 9869, 2013, pp. 783–85.

Chicago Style

Sooriakumaran, P, and C Anderson. 2013. “Everolimus for Renal Angiomyolipoma in Tuberous Sclerosis.” Lancet 381 (9869): 783–85.
Print

Access Document

Publisher copy:: 10.1016/s0140-6736(12)61954-0

Authors

+ Sooriakumaran, P More by this author

Institution:: University of Oxford
Division:: MSD
Department:: Surgical Sciences
Role:: Author

+ Anderson, C More by this author

Role:: Author

Journal:: Lancet More from this journal
Volume:: 381
Issue:: 9869
Pages:: 783-785
Publication date:: 2013-03-01
DOI:: 10.1016/s0140-6736(12)61954-0
EISSN:: 1474-547X
ISSN:: 0140-6736

Language:: English
Keywords:: Female

Sirolimus

Antineoplastic Agents

Male

Angiomyolipoma

Humans
Pubs id:: pubs:414543
UUID:: uuid:69b823cd-21ea-454a-9c08-2c1b04ef3228
Local pid:: pubs:414543
Source identifiers:: 414543
Deposit date:: 2013-11-16
ARK identifier:: ark:/29072/ora_69b823cd21ea454a9c082c1b04ef3228

Terms of use

Copyright date:: 2013

Licence:: Terms and Conditions of Use for Oxford University Research Archive

Views and Downloads

Views and downloads will return soon

If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP